Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (471-480 of 654) with videos related to

Pageof 66
Sort By:
JAMA Psychiatry|April 7, 2016
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical TrialEugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDongping Wei, Leslie A Parsels, David Karnak, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonistsDavid G Witte, Michael E Brune, Sweta P Katwala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 1991
Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in ratsC G Yeh, H C Marsh, G R Carson, et al.
Pain Physician|January 12, 2016
Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance TreatmentBrittany B Dennis, Pavel S Roshanov, Monica Bawor, et al.
Substance Abuse Treatment, Prevention, and Policy|September 17, 2021
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatmentHeather Palis, Kirsten Marchand, Gerald Spike Peachey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patientsBenjamin T Gielda, James C Marsh, Thomas W Zusag, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survivalBenjamin T Gielda, Par Mehta, Atif Khan, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective propertiesS P Arneric, J P Sullivan, M W Decker, et al.
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Pageof 66

Showing results (471-480 of 654) with videos related to

Sort By:
Pageof 66
JAMA Psychiatry|April 7, 2016
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical TrialEugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDongping Wei, Leslie A Parsels, David Karnak, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 24, 2002
Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonistsDavid G Witte, Michael E Brune, Sweta P Katwala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 1991
Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in ratsC G Yeh, H C Marsh, G R Carson, et al.
Pain Physician|January 12, 2016
Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance TreatmentBrittany B Dennis, Pavel S Roshanov, Monica Bawor, et al.
Substance Abuse Treatment, Prevention, and Policy|September 17, 2021
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatmentHeather Palis, Kirsten Marchand, Gerald Spike Peachey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patientsBenjamin T Gielda, James C Marsh, Thomas W Zusag, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survivalBenjamin T Gielda, Par Mehta, Atif Khan, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective propertiesS P Arneric, J P Sullivan, M W Decker, et al.
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Pageof 66